Rezolute (RZLT) announced that the U.S. Food and Drug Administration, FDA, has granted Breakthrough Therapy Designation, BTD, to ersodetug, ...

Breakthrough Therapy Designation granted based on key positive data from the Phase 2b (RIZE) study and current unmet medical need in congenital ...

Glycemic and hypoglycemia treatment targets should be individualized and reassessed every 3–6 months. If targets are not met, one diabetes technology—continuous subcutaneous insulin infusion ...

In view of its prompt and sustained effectiveness, diazoxide currently appears to be the agent of choice in the pharmacologic treatment of chronic hypoglycemia in children as well as adults.

Hypoglycemia is the major barrier to good glycemic control in patients with diabetes mellitus. Furthermore, randomized controlled trials have emphasized the grave risks associated with severe ...

Phase 1 results support proceeding to Phase 2 in patients with post-bariatric hypoglycemia (PBH), which is expected to begin in 2H 2025 Phase 1 trial in healthy volunteers showed MBX 1416 was generall ...

The severity of low blood sugar symptoms determines what treatment is necessary. In severe cases of hypoglycemia, a person may not be able to self-administer their diabetes medication, or the time ...

J. Miranda Rosenthal1,2, Stephanie A. Amiel1, Lidia Yágüez2,3, Edward Bullmore2, David Hopkins1, Mark Evans1, Andrew Pernet1, Helen Reid1, Vincent Giampietro2 ...

Considering taking supplements to treat hypoglycemia? Below is a list of common natural remedies used to treat or reduce the symptoms of hypoglycemia. Follow the links to read common uses ...

- Dan Monahan will lead the commercialization strategy across Amylyx’ product portfolio, beginning with avexitide, an investigational, first-in-class glucagon-like peptide-1 (GLP-1) receptor ...

Symptoms include tiredness, blurred vision, excessive sweating, and dizziness. Hypoglycemia is easily detected by measuring glucose levels. Can usually be self-diagnosed Rarely requires lab test ...